• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Mac Charles (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
507836
INE435D01014
275.4885496
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MCCHRLS-B
61.09
915.49
EPS(TTM)
Face Value()
Div & Yield %
11.44
10
0
 

Glenmark Pharmaceuticals consolidated net profit rises 6381.94% in the March 2026 quarter
May 30,2026
Net profit of Glenmark Pharmaceuticals rose 6381.94% to Rs 301.41 crore in the quarter ended March 2026 as against Rs 4.65 crore during the previous quarter ended March 2025. Sales rose 16.77% to Rs 3760.28 crore in the quarter ended March 2026 as against Rs 3220.13 crore during the previous quarter ended March 2025.

For the full year,net profit rose 30.06% to Rs 1361.85 crore in the year ended March 2026 as against Rs 1047.10 crore during the previous year ended March 2025. Sales rose 27.12% to Rs 16711.40 crore in the year ended March 2026 as against Rs 13145.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3760.283220.13 17 16711.4013145.84 27
OPM %20.2817.42 -27.3617.89 -
PBDT909.08506.00 80 4824.312258.04 114
PBT761.17380.79 100 4250.831772.03 140
NP301.414.65 6382 1361.851047.10 30